CHIA-YU CHUCHIH-HSIN YANGYang C.-Y.Hsiao G.-H.HSIEN-CHING CHIU2020-05-262020-05-2620000007-0963https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034100326&doi=10.1046%2fj.1365-2133.2000.03432.x&partnerID=40&md5=ee19d38d4039aef7f000294542985e18https://scholars.lib.ntu.edu.tw/handle/123456789/495159Docetaxel (Taxotere?), a semisynthetic taxoid, acts as an antimicrotubule agent and is considered to have great potential in the treatment of non-small cell lung cancer, advanced breast cancer, ovarian cancer and some other tumours. Well-recognized side-effects include dose- limiting neutropenia, fluid retention, myalgia, neuropathy, hypersensitivity reaction, alopecia, mucositis, nail changes and cutaneous reactions such as acral erythema. We describe a unique docetaxel-induced cutaneous reaction presenting as fixed erythematous plaque(s) unrelated to extravasation or previous skin injury; histopathological studies were performed in three of the four cases.[SDGs]SDG3docetaxel; advanced cancer; alopecia; article; breast carcinoma; case report; drug hypersensitivity; drug induced disease; erythrodysesthesia; female; fluid retention; human; human tissue; lung adenocarcinoma; lung non small cell cancer; male; mucosa inflammation; myalgia; neutropenia; ovary carcinoma; priority journal; skin defect; Adult; Antineoplastic Agents, Phytogenic; Drug Eruptions; Erythema; Female; Humans; Injections, Intravenous; Male; Middle Aged; Paclitaxel; ParesthesiaFixed erythrodysaesthesia plaque due to intravenous injection of docetaxeljournal article10.1046/j.1365-2133.2000.03432.x107922382-s2.0-0034100326